TRIM33 and acute myeloid leukemia: In contrast, TRIM33 knockdown led to negligible effects on the viability of MLL-AF9/NrasG12D AML and Notch-mutant T-cell acute lymphoblastic leukemia (T-ALL) (Figure 1D,E).